BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 11583309)

  • 1. Von Willebrand factor, type 2 diabetes mellitus, and risk of cardiovascular disease: the framingham offspring study.
    Frankel DS; Meigs JB; Massaro JM; Wilson PW; O'Donnell CJ; D'Agostino RB; Tofler GH
    Circulation; 2008 Dec; 118(24):2533-9. PubMed ID: 19029465
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chen CM; Houng JY; Ko TL; Juan SH; Chou HC
    Evid Based Complement Alternat Med; 2022; 2022():3323745. PubMed ID: 35966750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical role of von Willebrand factor in acute ischemic stroke.
    Menih M; Križmarić M; Hojs Fabjan T
    Wien Klin Wochenschr; 2017 Jul; 129(13-14):491-496. PubMed ID: 28409234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients.
    Wang M; Corsetti J; McNitt S; Rich DQ; Sparks CE; Moss AJ; Zareba W
    J Clin Lipidol; 2017; 11(1):215-223. PubMed ID: 28391888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies.
    Yarmolinsky J; Bordin Barbieri N; Weinmann T; Ziegelmann PK; Duncan BB; Inês Schmidt M
    Sci Rep; 2016 Jan; 6():17714. PubMed ID: 26813008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of ultrafine particles in persons with type 2 diabetes.
    Stewart JC; Chalupa DC; Devlin RB; Frasier LM; Huang LS; Little EL; Lee SM; Phipps RP; Pietropaoli AP; Taubman MB; Utell MJ; Frampton MW
    Environ Health Perspect; 2010 Dec; 118(12):1692-8. PubMed ID: 20822968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.
    Kalofoutis C; Piperi C; Kalofoutis A; Harris F; Phoenix D; Singh J
    Exp Clin Cardiol; 2007; 12(1):17-28. PubMed ID: 18650975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of diabetes mellitus on heart failure risk and outcome.
    Bauters C; Lamblin N; Mc Fadden EP; Van Belle E; Millaire A; de Groote P
    Cardiovasc Diabetol; 2003 Jan; 2():1. PubMed ID: 12556246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocrine system in diabetes mellitus.
    Alrefai H; Allababidi H; Levy S; Levy J
    Endocrine; 2002 Jul; 18(2):105-19. PubMed ID: 12374457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.